Teses dirixidas (205) Teses dirixidas por miembros de Departamento académico Ver tese defendida

2023

  1. Albumin based-nanoparticles as a platform for oral and intravenous delivery of monoclonal antibodies

    Pangua-Irigaray, Cristina

    Dirixida por Juan Manuel Irache Garreta y María Socorro Espuelas Millán
  2. Exploring novel se-compounds as promising therapeutical option for leishmaniasis management

    Henríquez-Figuereo, Andreina

    Dirixida por Carmen Sanmartín Grijalba y Daniel Plano Amatriain
  3. Mechanistic modelling of immuno-modulators in oncology drug development

    Sancho Araiz, Aymara

    Dirixida por José Ignacio Fernández de Trocóniz Fernández
  4. Nanomedicines for the Treatment of Pediatric Neuroblastoma

    el Moukhtari, Souhaila H.

    Dirixida por María Blanco Prieto
  5. Synthesis and Preclinical Development of novel Organoselenium compounds as Multi-Target and Bioactive Agents

    Astrain-Redín, Nora

    Dirixida por Carmen Sanmartín Grijalba
  6. Unravelling the role of SIRT2 in Alzheimer’s disease

    Sola-Sevilla, Noemí

    Dirixida por Elena Puerta Ruiz de Azua y Maite Solas Zubiaurre

2022

  1. Biosafety evaluation of an antiseptic formulation containing silver nanoparticles

    Rodríguez-Garraus, A.

    Dirixida por Adela López de Cerain Salsamendi y Amaya Azqueta Oscoz
  2. Biosafety evaluation of an antiseptic formulation containing silver nanoparticles/evaluación de la bioseguridad de una formulación antiséptica que contiene nanopartículas de plata

    RODRIGUEZ GARRAUS, ADRIANA

    Dirixida por Amaya Azqueta Oscoz y Adela López de Cerain Salsamendi
  3. Design and synthesis of new selenoderivatives with biomedical applications

    Ramos-Inza, Sandra

    Dirixida por Carmen Sanmartín Grijalba y Daniel Plano Amatriain
  4. Impact of astrocytic GLUT1 ablation on glucose homeostasis and cognition

    García-Ardanaz, C.

    Dirixida por Maite Solas Zubiaurre y María Javier Ramírez Gil
  5. Improvement of the bioavailability of quercetin encapsulated in zein-based nanoparticles. Effects on a Diet-Induced Obesity model

    Campión-Rodríguez, R.

    Dirixida por Juan Manuel Irache Garreta y Carlos Javier González Navarro
  6. Moléculas pequeñas conteniendo selenio como agentes antitumorales: Síntesis y Desarrollo preclínico

    Calvo-Martín, G.

    Dirixida por Daniel Plano Amatriain y Carmen Sanmartín Grijalba
  7. Origanum vulgare L. spp. vulgare: Chemical characterisation, pharmacological screening and design of new pharmaceutical forms

    de Torre, M. P.

    Dirixida por María Isabel Calvo Martínez y Rita Yolanda Cavero Remón
  8. Pharmacometrics to facilitate decision-making in pain research and perioperative management

    Marco-Ariño, N.

    Dirixida por José Ignacio Fernández de Trocóniz Fernández
  9. Role of HDAC5 and SIRT2 in depression and clinical efficacy of antidepressants

    Cortés-Erice, M.

    Dirixida por Rosa María Tordera Baviera
  10. Therapeutic potential of zein-based nanoparticles

    Reboredo-Fuentes, C.

    Dirixida por Juan Manuel Irache Garreta y Carlos Javier González Navarro
  11. Toxicological evaluation of mycotoxin mixtures: development of in vitro testing strategies and in vivo assessment of a binary mixture

    Alonso-Jáuregui, María

    Dirixida por Ariane Vettorazzi Armental y María Elena González Peñas

2021

  1. Deciphering the connection between aging, insulin resistance and cognitive decline in Alzheimer's disease: role of TMAO as linking mechanism

    Janeiro-Arenas, M. H.

    Dirixida por María Javier Ramírez Gil y Maite Solas Zubiaurre
  2. Development of disease and drug models for rare diseases: Application to Acute Intermittent Porphyria

    Vera-Yunca, D.

    Dirixida por José Ignacio Fernández de Trocóniz Fernández y Zinnia Patricia Parra Guillén
  3. Development of three-dimensional biomaterials containing stem cells and neurotrophic factors for brain repair in Parkinson's disease

    Torres-Ortega, P. V.

    Dirixida por Elisa Garbayo Atienza y María Blanco Prieto